BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 101 filers reported holding BIOSCRIP INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $46,000 | +58.6% | 16,802 | 0.0% | 0.00% | – |
Q1 2017 | $29,000 | +70.6% | 16,802 | 0.0% | 0.00% | – |
Q4 2016 | $17,000 | -65.3% | 16,802 | 0.0% | 0.00% | – |
Q3 2016 | $49,000 | +14.0% | 16,802 | 0.0% | 0.00% | – |
Q2 2016 | $43,000 | +19.4% | 16,802 | 0.0% | 0.00% | – |
Q1 2016 | $36,000 | +5.9% | 16,802 | -12.6% | 0.00% | – |
Q4 2015 | $34,000 | -5.6% | 19,224 | 0.0% | 0.00% | – |
Q3 2015 | $36,000 | -48.6% | 19,224 | 0.0% | 0.00% | – |
Q2 2015 | $70,000 | -17.6% | 19,224 | +0.1% | 0.00% | – |
Q1 2015 | $85,000 | -36.6% | 19,212 | 0.0% | 0.00% | – |
Q4 2014 | $134,000 | +0.8% | 19,212 | 0.0% | 0.00% | – |
Q3 2014 | $133,000 | -16.9% | 19,212 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $160,000 | +19.4% | 19,212 | 0.0% | 0.00% | – |
Q1 2014 | $134,000 | -5.6% | 19,212 | 0.0% | 0.00% | – |
Q4 2013 | $142,000 | -16.0% | 19,212 | 0.0% | 0.00% | -100.0% |
Q3 2013 | $169,000 | -46.7% | 19,212 | 0.0% | 0.00% | -66.7% |
Q2 2013 | $317,000 | – | 19,212 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |